What impact have NICE guidelines had on the trends of hip arthroplasty since their publication?

Roberts, V. I.; Esler, Colin; Harper, W. M.

doi:10.1302/0301-620x.89b7.18593

Cited by 21 publications

(7 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One recent study, for example, shows that 86.4% of obstetric units the UK study exceeded the maximum dose of intravaginal prostagland used to induce labour recommended by NICE [38]. Roberts et al [39] found that cemented hip prostheses fell between 2001 and 2005-that is after NICE guidance supporting use of cemented prosthesis in 2000. Over the same period the use of hybrid prosthesis more than doubled (from 8.8% to 22%), in contravention of the NICE guidance.…”

Section: The Impact Of Guidelines On Practicementioning

confidence: 99%

Does social marketing provide a framework for changing healthcare practice?

Morris

Clarkson

2009

Health Policy

View full text Add to dashboard Cite

Section: The Impact Of Guidelines On Practicementioning

confidence: 99%

Does social marketing provide a framework for changing healthcare practice?

Morris

Clarkson

2009

Health Policy

View full text Add to dashboard Cite

“…For example, a population-based assessment of performance on 439 recommendations for 30 conditions spanning preventive, acute, and chronic care services found that only 55% of patients in the United States received recommended care (18). In addition, the lack of adherence to practice guidelines continues to be identified worldwide across different conditions and settings of care (19)(20)(21)(22)(23)(24)(25).…”

mentioning

confidence: 99%

An Update of Comprehensive Evidence-Based Guidelines for Interventional Techniques in Chronic Spinal Pain. Part I: Introduction and General Considerations

Manchikanti

2013

Pain Phys

View full text Add to dashboard Cite

In 2011, the Institute of Medicine (IOM) re-engineered its definition of clinical guidelines as follows: “clinical practice guidelines are statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefit and harms of alternative care options.” This new definition departs from a 2-decade old definition from a 1990 IOM report that defined guidelines as “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.” The revised definition clearly distinguishes between the term “clinical practice guideline” and other forms of clinical guidance derived from widely disparate development processes, such as consensus statements, expert advice, and appropriate use criteria. The IOM committee acknowledged that for many clinical domains, high quality evidence was lacking or even nonexistent. Even though the guidelines are important decisionmaking tools, along with expert clinical judgment and patient preference, their value and impact remains variable due to numerous factors. Some of the many factors that impede the development of clinical practice guidelines include bias due to a variety of conflicts of interest, inappropriate and poor methodological quality, poor writing and ambiguous presentation, projecting a view that these are not applicable to individual patients or too restrictive with elimination of clinician autonomy, and overzealous and inappropriate recommendations, either positive, negative, or non-committal. Consequently, a knowledgeable, multidisciplinary panel of experts must develop guidelines based on a systematic review of the existing evidence, as recently recommended by the IOM. Chronic pain is a complex and multifactorial phenomenon associated with significant economic, social, and health outcomes. Interventional pain management is an emerging specialty facing a disproportionate number of challenges compared to established medical specialties, including the inappropriate utilization of ineffective and unsafe techniques. In 2000, the American Society of Interventional Pain Physicians (ASIPP) created treatment guidelines to help practitioners. There have been 5 subsequent updates. These guidelines address the issues of systematic evaluation and ongoing care of chronic or persistent pain, and provide information about the scientific basis of recommended procedures. These guidelines are expected to increase patient compliance; dispel misconceptions among providers and patients, manage patient expectations reasonably; and form the basis of a therapeutic partnership between the patient, the provider, and payers. Key words: Evidence-based medicine (EBM), comparative effectiveness research (CER), clinical practice guidelines, systematic reviews, meta-analysis, interventional pain management, evidence synthesis, methodological quality assessment, clinical relevance, recommendations.

show abstract

“…Indeed the NHS has an obligation to implement NICE technology assessments within three months of publication [3] . However, uptake of new guidance can be suboptimal [4] , [5] , [6] , [7] , [8] , [9] . For example, heat maps for the use of medical technologies and primary care medicines show that there is wide variation between the medicines patients can access in one part of England compared with other parts [4] .…”

Section: Introductionmentioning

confidence: 99%

Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?

et al. 2016

View full text Add to dashboard Cite

BackgroundTimely implementation of recommended interventions can provide health benefits to patients and cost savings to the health service provider. Effective approaches to increase the implementation of guidance are needed. Since investment in activities that improve implementation competes for funding against other health generating interventions, it should be assessed in term of its costs and benefits.ObjectiveIn 2010, the National Institute for Health and Care Excellence released a clinical guideline recommending natriuretic peptide (NP) testing in patients with suspected heart failure. However, its implementation in practice was variable across the National Health Service in England. This study demonstrates the use of multi-period analysis together with diffusion curves to estimate the value of investing in implementation activities to increase uptake of NP testing.MethodsDiffusion curves were estimated based on historic data to produce predictions of future utilization. The value of an implementation activity (given its expected costs and effectiveness) was estimated. Both a static population and a multi-period analysis were undertaken.ResultsThe value of implementation interventions encouraging the utilization of NP testing is shown to decrease over time as natural diffusion occurs. Sensitivity analyses indicated that the value of the implementation activity depends on its efficacy and on the population size.ConclusionsValue of implementation can help inform policy decisions of how to invest in implementation activities even in situations in which data are sparse. Multi-period analysis is essential to accurately quantify the time profile of the value of implementation given the natural diffusion of the intervention and the incidence of the disease.

show abstract

What impact have NICE guidelines had on the trends of hip arthroplasty since their publication?

Cited by 21 publications

References 8 publications

Does social marketing provide a framework for changing healthcare practice?

Does social marketing provide a framework for changing healthcare practice?

An Update of Comprehensive Evidence-Based Guidelines for Interventional Techniques in Chronic Spinal Pain. Part I: Introduction and General Considerations

Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?

Contact Info

Product

Resources

About